InvestorsHub Logo
Post# of 11526
Next 10
Followers 516
Posts 38725
Boards Moderated 5
Alias Born 04/26/2012

Re: None

Saturday, 02/04/2017 1:49:46 AM

Saturday, February 04, 2017 1:49:46 AM

Post# of 11526
Silicon Valley biotech trading at .007!!!.....and heading up, ARYC, many updates:

Arrayit Silicon Valley store sales exceed $54 million all-time on 222,269 microarray products and services
http://
shop.arrayit.com

Arrayit receives new financing lead that could generate 6,000 x $100K = $600MM in Arrayit microarray platform sales
http://
arrayit.com

Arrayit signs 3-year $24.4 million patented microarray technology sales and marketing agreement with a leading laboratory services provider.

Arrayit Corporation ?@arrayit
Arrayit quotes $16,000,000 microarray services contract to top US-based research laboratory http://arrayit.com/Services/services.html

Arrayit backorders soar to record $2.5MM on strong demand for microarray products & services
http://
arrayit.com/index.html

Arrayit Corporation

http://www.arrayit.com/

Check out their Facebook page: Arrayit Corporation

Follow $ARYC on Twitter @Arrayit

Avant Diagnostics, Inc. provide the market’s first large panel biomarker monitoring test for ovarian cancer (OVC). OvaDx® is advanced microarray-based test that measures the activation of the immune system in blood samples in response to early stage ovarian tumor cell development. Research studies with OvaDx® indicate high sensitivity and specificity for all types and stages of ovarian cancer including stage IA-IV borderline serous, clear cell, endometrioid, mixed epithelial, mucinous, serous, and ovarian adenocarcinoma. Upon FDA approval, Avant will offer OvaDx® as an elective test for women seeking greater wellness and for women in the elevated risk category for ovarian cancer. OvaDx® will be used by doctors to advance the forefront of ovarian cancer treatment including improved surgical options, more effective chemotherapies, and to supplement existing tests including CA-125, OVA1®, and transvaginal ultrasound.

Arrayit manufacturing team completes 20,000 blood card production run with $6.9M 2017 life science revenue potential
(link: http://arrayit.com/Products/Protein_Microarrays/Blood_Card/blood_card.html)
arrayit.com/Products/Prote…

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.